Theradaptive is revolutionizing the field of therapeutic delivery with a pipeline of first-in-class and best-in-class products that address an $80B global market. Our computational platform can convert any recombinant protein into a material-binding variant that behaves like a paint and can be used to coat implants, devices, and injectable carriers to enable long-term local delivery with no off-target effects. We are going after previously out-of-reach clinical indications in vascular, soft tissue, and orthopedic repair as well as targeted chemotherapeutics.

Contact Theradaptive
Visit Website